C
Cullinan Therapeutics, Inc.
CGEM · NASDAQ · Healthcare · 1.3B
Price · close
$21.68
+1.40% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.1×
Enterprise value / EBITDAEV/EBITDA
-5.4×
Free cash flow yieldFCF yield
-13.7%
Return on equityROE
-53.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.